Sun Life Financial Inc United Therapeutics Corp Transaction History

Sun Life Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$78.31 - $95.34 $177,685 - $216,326	-2,269 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$74.85 - $85.99 $21,706 - $24,937	290 Added 14.65%	2,269 $181,000
Q2 2019 Aug 08, 2019	BUY	$76.06 - $120.81 $15,212 - $24,162	200 Added 11.24%	1,979 $154,000
Q1 2019 May 14, 2019	BUY	$107.15 - $126.84 $1,071 - $1,268	10 Added 0.57%	1,779 $209,000
Q4 2018 Feb 06, 2019	BUY	$101.4 - $128.73 $912 - $1,158	9 Added 0.51%	1,769 $193,000
Q3 2018 Nov 13, 2018	BUY	$113.81 - $129.46 $1,251 - $1,424	11 Added 0.63%	1,760 $225,000
Q2 2018 Aug 09, 2018	BUY	$101.14 - $118.31 $176,893 - $206,924	1,749 New	1,749 $198,000

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Sun Life Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Sun Life Financial Inc with notifications on news.